Concepedia

Pierre Bonneau

PB

40

Publications

3.3K

Citations

29

H-Index

1991

Active since

Affiliations

Boehringer Ingelheim (Canada)(Current)

Boehringer Ingelheim (Germany)

Boehringer Ingelheim (Egypt)

Biotechnology Research Institute

Pierre Bonneau is an author at Boehringer Ingelheim (Canada) specializing in medicine, drug discovery, and natural sciences.

Top concepts

Publications per year

1991–2019

40

Publications

40

An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

Daniel Lamarre, Paul C. Anderson, Murray D. Bailey et al. · Nature · 2003 · 911 citations

, , +9

Macrocyclic Inhibitors of the NS3 Protease as Potential Therapeutic Agents of Hepatitis C Virus Infection

Youla S. Tsantrizos, Gordon T. Bolger, Pierre Bonneau et al. · Angewandte Chemie International Edition · 2003 · 188 citations

, , +17

Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1

Lee D. Fader, Éric Malenfant, Mathieu Parisien et al. · ACS Medicinal Chemistry Letters · 2014 · 175 citations · Full text

, , +16

Functional expression of human cathepsin S in Saccharomyces cerevisiae. Purification and characterization of the recombinant enzyme.

Dieter Brömme, Pierre Bonneau, Paule Lachance et al. · Journal of Biological Chemistry · 1993 · 164 citations · Full text

A new serine-protease fold revealed by the crystal structure of human cytomegalovirus protease

Liang Tong, Chungeng Qian, Marie-Josée Massariol et al. · Nature · 1996 · 157 citations

, , +11

Rows per page

1–5 of 40